Submissions from 2024
Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer, Andrew Barsky, Andrew Wroe, Kathryn Mittauer, Adeel Kaiser, Roberto Herrera, Jen Yu, Alonso Gutierrez, Diane Alvarez, James McCulloch, Michael Kasper, Minesh Mehta, and Michael Chuong
Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group, Noah Kalman and Robert Press
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas, Minesh Mehta
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma, Minesh Mehta
Modified Bethesda criteria for thyroid aspirates significantly decrease nondiagnostic rates without decreasing sensitivity, Andrew Renshaw, Brian Schiro, Neeta Erinjeri, and Robert Udelsman
The joy of surgery: how gender influences surgeons' experiences, Horacio Asbun
Genomic alterations associated with postoperative nodular leptomeningeal disease after resection of brain metastases, Michael McDermott
Multidisciplinary Management of Isocitrate Dehydrogenase-Mutated Gliomas in a Contemporary Molecularly Defined Era, Rupesh Kotecha and Minesh Mehta
A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR), Manmeet Ahluwalia, Ahmad Ozair, and Atulya Khosla
Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy for Painful Spinal Metastases: A Comparative Analysis of Randomized Trials and Practical Considerations, Omer Gal, Robert Rothrock, Alonso Gutierrez, Minesh Mehta, and Rupesh Kotecha
Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial, Ana Sandoval Leon
The joy of surgery: how surgeons experience joy, time, and support, Horacio Asbun
Serum Lipoproteins Are Associated With Coronary Atherosclerosis in Asymptomatic U.S. Adults Without Traditional Risk Factors, Ricardo Cury, Theodore Feldman, Jonathan Fialkow, and Khurram Nasir
Impact of Poverty on Stroke Recurrence: A Population-Based Study, Felipe De Los Rios La Rosa
Evaluating the sensitivity of EQ-5D-5L in patients with brain metastases: a secondary analysis of NRG CC001, Minesh Mehta
Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis, Tugce Kutuk, Yanjia Zhang, Eyub Akdemir, Sreenija Yarlagadda, Ranjini Tolakanahalli, Matthew Hall, Alonso La Rosa De Los Rios, D Jay Wieczorek, Cecilia Lee, Haley Appel, Michael McDermott, Yazmin Odia, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, Rupesh Kotecha, and Robert Press
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT, Manmeet Ahluwalia and Ahmad Ozair
Survival outcomes of small cell variant bladder cancer: Analysis from a nationwide study, Mohammad Ganiyani, Saba Ahmad, Muni Rubens, Mukesh Roy, Bruno Bastos, Manuel Ozambela Jr, and Murugesan Manoharan
A multicenter phase 1 trial of tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2–positive breast cancer (TUTOR), Manmeet Ahluwalia, Ahmad Ozair, Mainak Bardhan, Dilanis Perche, Muni Rubens, Yazmin Odia, Rupesh Kotecha, Daniel Leon Ariza, Michael McDermott, Ana Cristina Sandoval Leon, Reshma Mahtani, Shreyas Bellur, and David Peereboom
A multicenter, randomized controlled phase 2b trial of survivin vaccine SurVaxM plus adjuvant temozolomide for newly diagnosed glioblastoma (SURVIVE), Manmeet Ahluwalia, Yazmin Odia, and Ahmad Ozair